LOWVELO Impact: riders helping fund research to fight triple-negative breast cancer
As South Carolina’s only National Cancer Institute-designated cancer center, the innovative research happening at Hollings impacts patients across the state and beyond. One of the people behind that lifesaving research is Hollings professor Philip H. Howe, Ph.D. Thanks to funding raised by LOWVELO riders, Howe’s research has the potential to change treatment strategies for patients with triple-negative breast cancer.
Rider-raised dollars fund innovative hereditary cancer research
With 100% of all rider-raised funds benefiting cancer research, LOWVELO supports a wide variety of research projects as well as fellowships and scholarships to help train the next generation of cancer researchers. In 2022, Hollings Cancer Center researcher Caitlin Allen, Ph.D. was awarded $25,000 from LOWVELO for her project.
